HHS replenishes smallpox vaccine supply: 3 things to know

HHS will restock the country’s supply of smallpox vaccines through a $170 million deal with Emergent BioSolutions, the agency announced Sept. 3.

Advertisement

Three things to know:

1. Emergent BioSolutions could receive up to $2.8 billion from HHS over the next 10 years to replenish the vaccine stockpile.

2. The Department of Defense uses some of the stockpiled vaccines to immunize military members traveling to high-risk areas.

3. HHS also stockpiles the vaccine as a biodefense measure. Few people are vaccinated against smallpox today, as the World Health Organization deemed the illness eradicated in 1980.

More articles on clinical leadership and infection control:
Nurse research prompts care improvements at Providence St. Joseph Health
Eleanor Health opens 1st outpatient addiction clinic in North Carolina
How Cincinnati Children’s cut hospitalization rates 20% among high-risk youth

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.